WASHINGTON (AP) – COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don’t work against the Omicron variant that now accounts for nearly all United States (US) infections, US health regulators said on Monday.
The Food and Drug Administration (FDA) said it was revoking emergency authorisation for both drugs, which were purchased by the federal government and have been administered to millions of Americans with COVID-19.
If the drugs prove effective against future variants, the FDA said it could re-authorise their use.
More details on Wednesday’s Borneo Bulletin
